Difference between revisions of "ZSCAN2-DT"
(Created page with "''ZKSCAN2-DT'', ==Annotated Information== ===Approved Symbol=== ''ZKSCAN2-DT'' ===Approved Name=== ''ZKSCAN2-DT'': ===Characteristics=== ''ZKSCAN2-DT'' is a long noncoding...") |
(→Approved Name) |
||
| Line 4: | Line 4: | ||
''ZKSCAN2-DT'' | ''ZKSCAN2-DT'' | ||
===Approved Name=== | ===Approved Name=== | ||
| − | ''ZKSCAN2-DT'': | + | ''ZKSCAN2-DT'': ZKSCAN2 divergent transcript, |
| − | + | CTD-2547G23.4 | |
===Characteristics=== | ===Characteristics=== | ||
Revision as of 03:09, 26 December 2018
ZKSCAN2-DT,
Contents
Annotated Information
Approved Symbol
ZKSCAN2-DT
Approved Name
ZKSCAN2-DT: ZKSCAN2 divergent transcript, CTD-2547G23.4
Characteristics
ZKSCAN2-DT is a long noncoding RNA with ensemble id ENSG00000274925. There is 1 noncoding exon and a Transcript length of 3115 bp [1].
Function
ZKSCAN2-DT play a key role in the progress of HCC through four hub genes, SRC, CREBBP, ADCY8 and PPARA [1].
Regulation
NA
Diseases
- Hepatocellular carcinoma [1].
Expression
ZKSCAN2-DT was significantly up-regulated in HCC samples. It is found that increased ZKSCAN2-DT expression was associated with the neoplasm histologic grade and vascular tumour cell type [1].
Labs working on this lncRNA
- Department of Medical Ultrasonics, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Zhuang Autonomous Region People’s Republic of China
- Department of Pathology, First Affiliated Hospital of Guangxi Medical University, Nanning, 530021 Guangxi Zhuang Autonomous Region People’s Republic of China
References
Sequence
Please input sequence here.
